Department of Biochemistry and Biotechnology, School of Pure and Applied Sciences, Kenyatta University, PO Box 43844-00100, Nairobi, Kenya
Received date: February 08, 2017; Accepted date: February 16, 2017; Published date: February 23, 2017
Citation: Koech SC, Ouko RO, Michael NM, Ireri MM, Ngugi MP, et al. (2017) Analgesic Activity of Dichloromethanolic Root Extract of Clutia abyssinica in Swiss Albino Mice. Nat Prod Chem Res 5:255. doi:10.4172/2329-6836.1000255
Copyright: © 2017 Koech SC, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Visit for more related articles at Natural Products Chemistry & Research
Pain as a sensory modality, represent a symptom for diagnosing various diseases and its associated conditions. Although it acts as a sensory modality in drawing attention to tissue injury, it is associated with poor quality of life and socioeconomic burden to the victim. Conventional synthetic drugs that are used to manage pain are not readily available and are associated with adverse effects. Thus, the use of herbal medicine from medicinal plants is an age old practice used by many communities to cure diseases. These medicinal plants are known to contain phytochemical compounds capable of relieving pain and healing diseases. C. abyssinica has been used traditionally by the Kallenjin community to alleviate various diseases. However, an extensive search of the literature reveals that no data has been documented about the medicinal use of the plant in suppressing pain. The present study thus, evaluated on analgesic potential of dichloromethanolic root extract of C. abyssinica in animal models. Thirty Swiss albino mice were grouped into six groups of five animal each; normal control, negative control, positive control and three experimental groups. The experimental animals were administered with the extract intraperitoneally at dose level of 50, 100 and 150 mg/ kg body weight. Acetic acid-induced pain was used to determine the analgesic activity of the extract. Diclofenac was used as a reference drug. The dichloromethanolic root extract reduced the number of abdominal writhing’s between 33.95% and 49.77% while the reference drug reduced the number of abdominal writhing’s by 46.51%. A number of phytochemical compounds associated with analgesic activity were observed to be present. The study therefore scientifically confirmed the traditional use of the medicinal plant in management of pain.
Pain; C. abyssinica; Herbal; Mice
The International association for the study of pain defines pain as “unpleasant sensory and emotional experience that is caused by actual or potential tissue damage”. The emotional component differs from one person to the other and in the same individual from time to time and it can be classified in several ways, but in therapeutic application into; nociceptive and neuropathic . In the body, Sensory nerve endings are generally found in every part of the body such as the blood vessels, internal organs, muscles, joints, and the skin . Damage caused by the chemical stimuli, mechanical stimuli, and thermal stimuli sensitize nociceptors. When cells are damaged a number of chemical mediators are released which then activate and sensitize nociceptors to other mediators of pain. Major mediators of pain include; Bradykinin, histamine, serotonin and prostaglandins . However, pain is beyond sensation, it comprises of perception and subjective interpretation of the discomfort . Sensation of pain is a sign that something in the body is wrong. Thus it plays an important role in drawing attention to tissue injury from harmful stimuli and reflexes are elicited to protect the injured part of the body .
In the brain, pain stimulus is processed and generated impulses are send down the spinal cord following the appropriate nerves and instructs the body to respond, for instance withdrawing your hand from the fire . Peripheral nerves transmit pain stimulus to the spinal cord which then links to the brain. Two types of nerve fibers are involved in this process; slow pain fibers and Fast pain fibers. Transmission of fast pain is through the Aδ fibers to the spinal cord while slow pain fibers is through the C-fibers. Fast pain nerve endings secrete neurotransmitter called glutamate, which transmits fast pain impulses to the brain in the cortex. Therefore localization of pain in certain part of the body becomes relatively precise .
Although pain is beneficial to the immune system. However, it causes a lot of suffering and discomfort to the victims, lowering the quality of life and therefore need to be managed. To suppress pain, NSAIDs are prescribed all over the world [6,7]. For severe or chronic malignant pain opioids analgesics are drugs of choice . However, prolonged use of these NSAIDs only provides asymptomatic relief and the greatest drawback lies in their toxicity to liver, kidney and gastrointestinal linings . In this regard, herbal medicines from medicinal plants have been employed in complementary and alternative medicine (CAM) for treatment of pain as well as diseases related to these conditions . Traditional medicinal herbs for over centuries have served as potential source for alternative medicine and the knowledge of herbal medicine has been passed on from generation to generation . Considering that most of analgesic, anti-malarial and anti-pyretic synthetic drugs such as aspirin, morphine, artemisinin, atrophine and chloroquine were derived from the plant products .
The use herbal medicine is gaining support and recognition across the world because most of these products are believed to have bioactive compounds responsible for healing various diseases without any side effects and at a lower cost. C. abyssinica is native to East Africa, Central Africa and South Africa . In East Africa roots and leafs of the plant are boiled and the soup taken as a remedy for chest pains, enlarged spleen and shortness of breath . Although, it has been used traditionally by the Kallenjin community in Kenya to treat pain and its associated conditions. However, the aforementioned folklore use of the plant lacks scientific validated data. Therefore, the aim of the study was to evaluate analgesic potential of dichloromethanolic roots extract of C. abyssinica in Swiss albino mice.
Plant sample collection and preparation
The roots sample were collected from Kaptebee village, turbo subcounty in Uasin Gishu county Kenya during the months of Januarymarch, a period in which the herbalist believed the medicinal plant had its utmost healing capacity to cure the named ailments. This process of collection of the plant sample was done with the guidance of a local herbalist. A voucher specimen consisting of fresh twigs with leaves was availed to an acknowledged taxonomist for botanical authentication. A sample voucher (NMK/BOT/CTX1/2) was deposited at the National Museum of Kenya herbarium. Sample roots were then sorted, cut into smaller pieces and cleaned with clean water and then air dried under shade for two weeks. Chopped root samples were packed into paper enveloped and transported to Kenyatta University laboratory where they were milled into fine powder using an electrical mill.
For extraction, 1.3 liters of dichloromethane was used to soak 400 g of the powdered root sample for 48 hours with occasional shaking within the first 10 hours to mix the sample uniformly on hourly basis. Whatman’s filter paper No.1 was used to filter the mixture. The filtrate was concentrated to dryness using the rotary evaporator at a temperature of 41°C. The concentrates was kept in sealed containers at low temperature until use in bio screening experiments.
Thirty Swiss albino mice weighing between 19-24 g were utilized for screening analgesic potential of DCM root extract of C. abyssinica. Standard laboratory cages were used to handle the experimental animals in the animal house at Kenyatta University. During the entire period of carrying out the research all the laboratory animals were kept in ambient room temperature for 12 hours darkness followed by 12 hours light cycles. Rodent pellets were used to feed the experimental animals and allowed access to water ad libitum. Rules and regulation for handling experimental animals in the study were adhered to .
Determination of analgesic effect
Analgesic activity of DCM root extract of C. abyssinica was determined through acetic acid-induced pain in experimental animals following the procedure described by  and . A total of thirty Swiss albino mice were grouped into 6 groups of five animals each. Prior to pain induction and administration of the experimental doses, all the experimental animals were fasted for 12 hours but were allowed access to water ad libitium. Pain was induced by injecting 3% acetic acid solution at a dose of 20 mL/kg body weight into the left side of the abdomen intraperitoneally. Immediately, after injection with aceticacid abdominal muscle constriction in the abdomen and turning of body trunk of the laboratory animal was seen as an indication of pain. The different groups were treated as follows; Group I (normal control) was administered with 10% DMSO only but pain was not induced. All the animals in group II (negative control) were induced with pain and administered with 10% DMSO. Those in group III (positive control) were induced with pain and administered with the reference drug (diclofenac 15 mg/kg body weight). Group IV-VI were induced with pain and administered with DCM root extract of C. abyssinica at dose levels of 50, 100 and 150 mg/kg body weight respectively. Table 1 indicates the summary of the design.
|I(Normal control)||10% DMSO only|
|II(Negative control)||3% Acetic acid|
|III (Positive control)||3% Acetic acid+diclofenac (15 mg/kg bw)|
|IV (Experimental group A)||3% cetic acid+C.abyssinica(50 mg/kg bw)|
|V (Experimental group B)||3% Acetic acid+C.abyssinica(100 mg/kg bw)|
|VI (Experimental group C)||3% Acetic acid+C.abyssinica(150 mg/kg bw)|
Table 1: Treatment protocol for assessment of analgesic activity of DCM root extract of C. abyssinicain Swiss albino mice.
Thirty minutes after different treatments were administered, each mouse in groups II−VI was intraperitoneally (ip) injected with 3% acetic acid into the left side of the abdomen at a dose of 20 ml/kg body weight to induce pain sensation except those in group I, which were administered with the vehicle (10% DMSO) only. Each mouse was then placed in a transparent observation box and the number of abdominal constrictions (writhes) for each mouse was counted for 30 minutes commencing 5 minutes after intraperitoneal injection of acetic acid. The percentage writhing inhibition was then calculated using the formula described by .
Where, C- The vehicle-treated control group; T - Treated group value.
Qualitative phytochemical screening
The plant extract was subjected to qualitative phytochemical screening to determine the presence or absence of various phytochemical compounds following a protocol described by . Flavonoids, phenolics, saponins, alkaloids cardiac glycosides, steroids and terpenoids were some of the phytochemical compounds tested. These secondary metabolites have been associated with analgesic activities (Table 2).
|Phytochemicals||DCM root extract of C.abyssinica|
Present phytochemicals denoted by (+), absent phytochemicals denoted by (-).
Table 2: Qualitative pphytochemical composition of DCM root extract of C. abyssinica.
Data management and statistical analysis
Raw data on the number of abdominal writhing was obtained from the experimental animals, recorded and tabulated on a broad sheet using Ms excel program. Data was then exported to Minitab version 17.0 for analysis. Data was subjected to descriptive statistics and results were expressed as Mean ± Standard Error of the Mean (SEM). One way ANOVA was used to analyse for statistical significance among the groups followed by Tukey’s test for separation of means and comparison of significant difference among the various groups. Data was presented in a Table 3. A value of P ≤ 0.05 was considered significant.
|Normal Control||10% DMSO||100.00 ± 0.0a|
|Negative Control||Acetic acid+DMSO||0.00 ± 0.0c|
|Positive Control||Acetic acid+Diclofenac (15 mg/kg bw)||46.51 ± 4.22b|
|Experimental group A||Aceticacid+C.abyssinica(50 mg/kg bw)||49.77 ± 4.69b|
|Experimental group B||Acetic acid+C.abyssinica(100 mg/kg bw)||38.60 ± 4.33b|
|Experimental group C||Acetic acid+C.abyssinica(150 mg/kg bw)||33.95 ± 8.01b|
Values are expressed as Mean ± SEM for five animals per group. Values with the same superscript letter are not significant different (one way ANOVA followed by Tukey’s test) (P>0.05).
Table 3: Analgesic activities of DCM root extracts of C. abyssinica on acetic acid-Induced pain in Swiss albino mice.
The DCM root extract of C. abyssinica demonstrated an analgesic activity in acetic acid-induced pain in Swiss albino male mice by reducing the number of abdominal writhes 30 minutes after the administration of the plant extract (Table 3). The intraperitoneal administration of DCM root extracts of C. abyssinica into Swiss albino mice at all the three dose levels (50, 100 and 150 mg/kg body weights), reduced the number of abdominal writhing by 49.3%, 38.6% and 33.95% respectively (Table 3). However, diclofenac (reference drug) reduced the number of abdominal writhes by 46.51% (Table 3). At a dose level of 50 mg/kg body weight, the extract demonstrated strong analgesic activity by reducing the number of abdominal writhes by 49.3% compared to the diclofenac (reference drug) which caused 46.1% reduction of abdominal writhes.
The analgesic effects of DCM root extract of C. abyssinica showed no significant difference at the three doses and were comparable to diclofenac (P>0.05; Table 3). The DCM root extract of C. abyssinica, at the three dose levels (50, 100 and 150 mg/kg body weight), reduced the number of abdominal writhing’s in a reverse dose dependent manner (Table 3).
To suppress pain conventionally, nonsteroidal anti-inflammatory drugs are prescribed . These drugs are used for treating various diseases such as arthritis, headache, pain and orthopedic conditions . Analgesic drugs such as diclofenac relieve pain peripherally/centrally by inhibiting cyclooxygenase enzyme (COX-1 and COX-2). Inhibition of cyclooxygenase enzyme reduces the production of pain mediators such as prostaglandins, substance P, histamine, serotonin, and Bradykinin. Pain sensation is eventually reduced in the nociceptors .
The DCM root extract of C. abyssinica in this study, exhibited analgesic activities by reducing the number of abdominal writhes in acetic acid-induced pain in male Swiss albino mice after treatment with the extract. After thirty minutes of test period, the DCM root extract at 50 mg/kg body weight demonstrated the highest analgesic activity by reducing the number of writhes by 49.77%, while 100 mg/kg body weight decreased the number of writhes by 38.6% and the dose of 150 mg/kg body weight decreased the number of writhes by 33.95% in a reverse dose dependent manner (Table 2).
These findings strongly suggest that the DCM root extract of C. abyssinica possess peripherally or centrally analgesic property. Perhaps acting in a similar manner as conventionally used therapeutic drugs that reduce the pain perception in nociceptors by inhibiting production of prostaglandins. These results concur with other research studies on the evaluation analgesic activity of herbal plants extract using laboratory animals. Reduction in the number of abdominal writhing’s in this study is in agreement with a study carried out by  on analgesic properties of acetone leaf extracts of Carissa spinarum in mice. The findings are also in line with studies by  on antinociceptive activity of Toddalia asiatica (L) Lam in models of central and peripheral pain.
The non-dose dependent analgesic activities of DCM root extract of C. abyssinica, are in agreement with a study carried out by  on analgesic activities of root and leaf extract of Carissa edulis in Wistar albino rats. The higher analgesic activity of a dose level of 50 mg/kg body weight than 150 mg/kg body weight (Table 3) might be attributed to the fact that when certain limits in dose ranges are exceeded, the activity of that particular agent is reduced. Also, high dose concentration of the extract could be taking longer time to be absorbed across peritoneum cavity. Analgesic effects produced by a lower dose was comparable to the reference drug, suggesting that the lower dose was more effective in managing pain induced by acetic acid. The dose range of (50, 100 and 150 mg/kg body weight) applied in bio screening of analgesic activities of DCM root extract in the study were comparable to dose ranges used by while evaluating the antipyretic, anti-inflammatory and analgesic activity of Acacia hydaspica R. Parker in animal models.
The analgesic activities of DCM root extract of C. abyssinica could be attributed to one or more of phytochemical compounds present in the extract (Table 2). Studies conducted on herbal plants by many researchers have linked presence of secondary active metabolites such as flavonoids, saponins and alkaloids to analgesic activities among other properties [28,29]. Flavonoids have the ability to disrupt synthesis of eicosanoids . Flavonoids also have the ability to reduce production of arachidonic acid through inhibition of neutrophils degranulation . Besides flavonoids, alkaloids also have been associated with the ability to inhibit pain perception . Alkaloids, for example berberine from berberies in a skeletal based pyridine ring have shown strong anti-inflammatory and antinociceptive activities . These mentioned phytochemicals were confirmed in preliminary phytochemical screening of DCM root extract of C. abyssinica (Table 2). Therefore, the phytochemicals found in the extract might have antagonized peripheral mediators of pain and thereby blocking transmission of pain.
The dichloromethanolic root extract of C. abyssinica demonstrated analgesic activities on acetic acid-induced pain in Swiss albino mice. The extract reduced the number of abdominal writhing’s significantly when compared to the reference drug (diclofenac). This study therefore concludes that the medicinal plant posses analgesic properties. Suppression of pain in this study could be attributed to phytochemical constituents present in the extract. Therefore, it is possible to obtain analgesic agent from the plant and serve as an alternative bio-resource in managing pain. However, further research on the mechanism action of the extract should be carried out. The study thus, scientifically confirms the traditional use of the medicinal plant in management of pain.
The authors are grateful to technical support provided by James Adino, Daniel Gitonga and James Ngujiri.